ResearcherSun Yat-sen UniversityActive in the last 2 years
Jiajia Li
Matched on ORCID iD 0000-0003-4281-0450; OpenAlex author ID A5100454311. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2016: 1 paper · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 3
- Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancreatic cancer. Co-author DOI 10.1039/d5nr90172c↗
- Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastasis via secreting IL-8. Co-author DOI 10.1002/cam4.1824↗
- A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy. Co-author DOI 10.1166/jbn.2016.2269↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yinting Chen · 3 shared papers, 2016–2025 · strength 0.40
- Paper Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancre… DOI 10.1039/d5nr90172c↗
- Paper Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastas… DOI 10.1002/cam4.1824↗
- Paper A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy. DOI 10.1166/jbn.2016.2269↗
- Guoda Lian · 3 shared papers, 2016–2025 · strength 0.40
- Paper Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancre… DOI 10.1039/d5nr90172c↗
- Paper Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastas… DOI 10.1002/cam4.1824↗
- Paper A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy. DOI 10.1166/jbn.2016.2269↗
- Linjuan Zeng · 3 shared papers, 2016–2025 · strength 0.40
- Paper Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancre… DOI 10.1039/d5nr90172c↗
- Paper Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastas… DOI 10.1002/cam4.1824↗
- Paper A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy. DOI 10.1166/jbn.2016.2269↗
- Yaqing Li · 3 shared papers, 2016–2025 · strength 0.40
- Paper Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancre… DOI 10.1039/d5nr90172c↗
- Paper Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastas… DOI 10.1002/cam4.1824↗
- Paper A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy. DOI 10.1166/jbn.2016.2269↗
- Kaihong Huang · 3 shared papers, 2016–2025 · strength 0.40
- Paper Correction: Nanoparticles modified by triple single chain antibodies for MRI examination and targeted therapy in pancre… DOI 10.1039/d5nr90172c↗
- Paper Tumor-driven like macrophages induced by conditioned media from pancreatic ductal adenocarcinoma promote tumor metastas… DOI 10.1002/cam4.1824↗
- Paper A Nanoparticle Carrier for Co-Delivery of Gemcitabine and Small Interfering RNA in Pancreatic Cancer Therapy. DOI 10.1166/jbn.2016.2269↗
- Shaojie Chen · 1 shared paper, 2025 · strength 0.26
- Jinmao Zou · 1 shared paper, 2025 · strength 0.26
- Shangxiang Chen · 1 shared paper, 2025 · strength 0.26
- Shaojie Chen · 2 shared papers, 2016–2018 · strength 0.14
- Kege Yang · 2 shared papers, 2016–2018 · strength 0.14
- Chumei Huang · 1 shared paper, 2018 · strength 0.08
- Qiubo Zhang · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.